-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Health
Latest From Health
JAMA Study Finds Vast Majority of Requests for Clinical Trial Data Granted
In 2014, BIO members reaffirmed and broadened their commitment to responsibly share data from clinical trials with other researchers, including academic and government researchers, in an effort to support additional efforts to improve public health. A JAMA study released yesterday shows that biopharmaceutical companies are keeping that commitment, approving the vast majority of requests for patient-level data from clinical trials. The study looked at three platforms containing clinical trial data from 14 drug companies. Of Read More >
ICYMI: John Lechleiter: An Empty Obama-Clinton-Sanders Plan on Drug Costs
Writing in the Wall Street Journal today, Eli Lilly and Company Chairman, President and CEO John Lechleiter examines proposals that would require pharmaceutical companies to disclose detailed information about the cost of R&D for individual drugs and the extent of discounts offered to insurers for each drug. Such proposals have been advanced in President Obama’s budget and on the campaign trail by Bernie Sanders and Hillary Clinton. But as Lechleiter explains, the key numbers are Read More >
March is National Colon Cancer Awareness Month
In 2000, President Clinton officially dedicated March as National Colon Cancer Awareness Month. Since then, it’s grown to be a rallying point for the colon cancer community, as thousands of patients, survivors, caregivers and advocates join together to spread awareness and raise funds for the cause. The nation’s oldest and largest nonprofit dedicated to the disease, the Colon Cancer Alliance, is encouraging everyone to support National Colon Cancer Awareness Month so the disease can be Read More >
Comparative Effectiveness Research Webinar
On Monday, March 14, the (NPC) will host a webinar on the relationship between comparative effectiveness research (CER) and the environment for health care decision-making. This is a noteworthy event that will feature Dr. Joe Selby, the executive director of the Patient-Centered Outcomes Research Institute, and other experts. Why is this webinar so significant? As every biopharmaceutical company knows, we’re on the verge of a new, golden era in medical innovation. The pipeline is filled Read More >
2016 Rare Disease Day at NIH: “Patients and Researchers – Partners for Life”
Rare Disease Day was established in 2008 in order to raise public awareness globally for rare and orphan diseases and shed light on the challenges that those who are affected by rare diseases face. This year, Rare Disease Day appropriately fell on the rarest day of all – February 29. To help with this global effort, the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) and NIH Clinical Center annually hosts Read More >
